Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020

SELL
$220.06 - $304.07 $220,060 - $304,070
-1,000 Closed
0 $0
Q2 2019

Jul 09, 2019

BUY
$219.29 - $241.72 $219,290 - $241,720
1,000 New
1,000 $234,000
Q1 2019

May 01, 2019

SELL
$216.71 - $338.96 $742,231 - $1.16 Million
-3,425 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$278.5 - $352.75 $953,862 - $1.21 Million
3,425 New
3,425 $603,000
Q3 2018

Oct 15, 2018

SELL
$293.51 - $383.83 $528,318 - $690,894
-1,800 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$257.52 - $306.91 $103,008 - $122,764
-400 Reduced 18.18%
1,800 $522,000
Q1 2018

Apr 30, 2018

BUY
$260.13 - $367.91 $104,052 - $147,164
400 Added 22.22%
2,200 $602,000
Q4 2017

Feb 06, 2018

SELL
$307.64 - $344.58 $123,056 - $137,832
-400 Reduced 18.18%
1,800 $573,000
Q3 2017

Oct 25, 2017

BUY
$281.15 - $329.69 $618,530 - $725,318
2,200
2,200 $689,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New Jersey Better Educational Savings Trust Portfolio

Follow New Jersey Better Educational Savings Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Jersey Better Educational Savings Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Jersey Better Educational Savings Trust with notifications on news.